Rheumatoid arthritis

Mitochondrial Medicine: Mitochondrial Metabolism, Diseases, Diagnosis and Therapy

Volumn , Issue , 2008, Pages 201-246

  Rovenský, Jozef ^a   Pavelka, Karel ^b  

^a NATIONAL INSTITUTE OF RHEUMATIC DISEASES   (Slovakia)

^b INSTITUTE OF RHEUMATOLOGY   (Czech Republic)

Author keywords

Chronic inflammation; disability; erosion of cartilage; extra articular manifestation; genetic predisposition; marginal bone; rheumatic nodules; rheumatoid arthritis; rheumatoid factors; severe joint disease; synovial membrane; therapy; vasculitis

Indexed keywords

EID: 82155202791     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4020-6714-3_11     Document Type: Chapter

References (59)

1. Albani S, Keystone EC, Nelson JL, Ollier WJ, LaCava A, Montemayor AC, Weber DA, Montecucco C, Martini A, Carson DA (1995) Positive selection in autoimmunity: Abnormal immune responses to a bacterial DNAJ antigenic determinant in patients with early rheumatoid arthritis. Nat Med 1:448-452.
2. Akiyama T, Mori S, Mashiba T, Miyamoto K, Komatsubara S, Cao Y, Manabe T, Norimatsu H, Dobashi H, Tokuda M (2005) Incadronate disodium inhibits joint destruction and periarticular bone loss only in the early phase of rat adjuvant-induced arthritis. J Bone Miner Metab 23:295-301.
3. Bauerova K, Bezek S (1999) Role of reactive oxygen and nitrogen species in etiopathogenesis of rheumatoid arthritis. Gen Physiol Biophys 18:15-20.
4. Bauerova K, Ponist S, Ondrejickova O, Komendova D, Mihalova D (2006) Association between tissue gamma-glutamyl-transferase and clinical markers of adjuvant arthritis in Lewis rats. Neuro Endocrinol Lett 27:172-175.
5. Billingham MEJ, Carney S, Butler R, Colston MJ (1990) A mycobacterial 65-kD heat shock protein induces antigen-specific suppression of adjuvant arthritis but is not itself arthritogenic. J Exp Med 171:339-344.
6. Björk J, Kleinau S, Midtvedt T, Klareskog L, Smedegård G (1994) Role of the bowel flora for development of immunity to hsp 65 and arthritis in three experimental models. Scand J Immunol 40:648-652.
7. Buckner JH, Nepom GT (2002) Genetics of rheumatoid arthritis: Is there a scientific explanation for the human leukocyte antigen association? Curr Opin Rheumatol 14:254-259.
8. Cannon GW, Woods ML, Clayton F, Griffiths MM (1993) Induction of arthritis in DA rats by incomplete Freund's adjuvant. J Rheumatol 20:7-11.
9. Cardoso SM, Pereira C, Oliveira CR (1999) Mitochondrial function is differently affected upon oxidative stress. Free Radic Biol Med 26:3-13.
10. Carlse'n S, Hansson AS, Olsson H, Heinegård D, Holmdahl R. (1998) Cartilage oligomeric matrix protein (COMP)-induced arthritis in rats. Clin Exp Immunol 114:477-484.
11. Chang YH, Pearson CM, Abe C (1980) Adjuvant polyarthritis. IV. Induction by a synthetic adjuvant: Immunologic, histopathologic, and other studies. Arthritis Rheum 23: 62-71.
12. Cohen IR (1991) Autoimmunity to chaperonins in the pathogenesis of arthritis and diabetes. Annu Rev Immunol 9:567-589.
13. Crofford LJ, Wilder RL (1997) Arthritis and autoimmunity in animals. In: Koopman W (ed.) Arthritis and Allied Conditions. Williams & Wilkins, Baltimore, MD, pp 565-583.
14. Cromartie WJ, Craddock JG, Schwab JH, Anderle SK, Yang CH (1977) Arthritis in rats after systemic injection of streptococcal cells or cell walls. J Exp Med 146:1585-1602.
15. Da Sylva TR, Connor A, Mburu Y, Keystone E, Wu GE (2005) Somatic mutations in the mitochondria of rheumatoid arthritis synoviocytes. Arthritis Tes Ther 7:R844-R851.
16. DePalma L, Chillemi C, Albanelli S, Rapali S, Bertoni-Freddari C (2000) Muscle involvement in rheumatoid arthritis: An ultrastructural study. Ultrastruct Pathol 24:151-156.
17. Dröge W (2002) Free radicals in the physiological control of cell function. Physiol Rev 82:47-95.
18. Feldmann M, Maini RN (2001) Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol 19:163-196.
19. Firestein GS (2003) Evolving concepts of rheumatoid arthritis. Nature 423:356-361.
20. Freund J (1947) Some aspects of active immunization. Ann Rev Microbiol 1:291-309.
21. Freund J (1956) The mode of action of immunologic adjuvants. Adv Tuberc Res 7:130-148.
22. Freund J, Lipton MM (1955) Experimental allergic encephalomyelitis after the excision of the injection site of antigen-adjuvant emulsion. J Immunol 75:454-459.
23. Halliwell B, Hoult JR, Blake DR (1988) Oxidants, inflammation, and anti-inflammatory drugs. FASEB J 2:2867-2873.
24. Holmdahl R, Goldschmidt TJ, Kleinau S, Kvick C, Jonsson R (1992) Arthritis induced in rats with adjuvant oil is a genetically restricted, alpha beta T-cell dependent autoimmune disease. Immunology 76:197-202.
25. Holmdahl R, Lorentzen JC, Lu S, Olofsson P, Holmberg LWJ, Pettersson U (2001) Arthritis induced in rats with non-immunogenic adjuvants as models for rheumatoid arthritis. Immunol Rev 184:184-202.
26. Holoshitz J, Naparstek Y, Ben-nun A, Cohen IR (1983) Lines of T lymphocytes induce or vaccinate against autoimmune arthritis. Science 219:56-59.
27. Jaswal S, Mehta HC, Sood AK, Kaur J (2003) Antioxidant status in rheumatoid arthritis and role of antioxidant therapy. Clin Chim Acta 338:123-129.
28. Joe B, Wilder RL (1999) Animal models of rheumatoid arthritis. Mol Med Today 5:367-369.
29. Karatas F, Ozates I, Canatan H, Halifeoglu I, Karatepe M, Colakt P (2003) Antioxidant status and lipid peroxidation in patients with rheumatoid arthritis. Indian J Med Res 118:178-181.
30. Kleinau S, Erlandsson H, Holmdahl R, Klareskog L (1991) Adjuvant oils induce arthritis in the DA rat. I. Characterization of the disease and evidence for an immunological involvement. J Autoimmun 4:871-880.
31. Kohashi O, Pearson CM, Watanabe Y, Kotani S (1977) Preparation of arthritogenic hydrosoluble peptidoglycans from both arthritogenic and non-arthritogenic bacterial cell walls. Inf Immun 16:861-866.
32. Kohashi O, Aihara K, Ozawa A, Kotani S, Azuma I (1982) New model of a synthetic adjuvant, N-acetylmuramyl-L-alanyl-Dtype isoglutamine-induced arthritis. Lab Invest 47: 27-36.
33. Larsson P, Holmdahl R, Dencker L, Klareskog L (1985) In vivo treatment with W3/13 (antipan T) but not with OX8 (anti-suppressor/cytotoxic T) monoclonal antibodies impedes the development of adjuvant arthritis in rats. Immunology 56:383-391.
34. Lin JP, Cash JM, Doyle SZ, Peden S, Kanik K, Amos CI, Bale SJ, Wilder RL (1998) Familial clustering of rheumatoid arthritis with other autoimmune diseases. Hum Genet 103:475-482.
35. Luft R (1995) The development of mitochondrial medicine. Biochim Biophys Acta 1271:1-6.
36. Luft R, Landau BR (1995) Mitochondrial medicine. J Int Med 238:405-421.
37. Maneiro E, Martin MA, deAndres MC, Lopez-Armada MJ, Fernandez-Sneiro JL, delHoyo P, Galdo F, Arenas J, Blanco J (2003) Mitochondrial respiratory activity is altered in osteoarthritic human articular chondrocytes. Arthritis Rheum 48:700-708.
38. Miesel R, Murphy MP, Kroger H (1996) Enhanced mitochondrial radical production in patients which rheumatoid arthritis correlates with elevated levels of tumor necrosis factor alpha in plasma. Free Radic Res 25:161-169.
39. Miro O, Pedrol E, Casademont J, Garcia-Carrasco M, Sanmarti R, Cebrian M, Gran JM. (1996) Muscle involvement in rheumatoid arthritis: clinicopathological study of 21 symptomatic cases. Semin Arthritis Rheum 25:421-428.
40. Nakazato S, Takase H, Yanagihara Y, Issekutz TB, Issekutz AC, Takai M, Kyogoku M (2005) Effect of G-1 column (Adacolumn) therapy in rats with adjuvant arthritis on the migration and immunoreactivity of peripheral and splenic leukocytes. Mod Rheumatol 15:249-257.
41. Nishimoto N, Yoshizaki K, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Hashimoto J, Azuma J, Kishimoto T (2004) Treatment of rheumatoid arthritis with humanized anti-interleukin- 6 receptor antibody: A multicenter, double-blind, placebo controlled trial. Arthritis Rheum 50:1761-1769.
42. Oldstone MBA (1989) Molecular mimicry as a mechanism for the cause and as a probe uncovering etiologic agent(s) of autoimmune disease. Curr Top Microbiol Immunol 145:127-135.
43. Ostrakhovitch EA, Afanasev IB (2001) Oxidative stress in rheumatoid arthritis leukocytes: Suppression by rutin and other antioxidants and chelators. Biochem Pharmacol. 15:743-746.
44. Ozturk HS, Cimen MY, Cinem OB, Kacmaz M, Durak I (1999) Oxidant/antioxidant status of plasma samples from patients with rheumatoid arthritis. Rheumatol Int 19:35-37.
45. Pearson CM (1956) Development of arthritis, periarthritis and perioscitis in rats given adjuvants. Proc Soc Exp Biol Med 91:95-101.
46. Pelegri C, Morante MP, Castellote C, Franch A, Castell M (1996) Treatment with an anti-CD4 monoclonal antibody strongly ameliorates established rat adjuvant arthritis. Clin Exp Immunol 103:273-278.
47. Sakaguchi S, Sakaguchi N (2005) Animal models of arthritis caused by systemic alteration of the immune system. Cur Opin Immunol 17:589-594.
48. Stoerck HC, Bielinski TC, Budzilovich T (1954) Chronic polyarthritis in rats injected with spleen in adjuvant. Am J Pathol 30:616.
49. Taurog JD, Sandberg GP, Mahowald ML (1983) The cellular basis of adjuvant arthritis. I. Enhancement of cellmediated passive transfer by concanavalin A and by immunosuppressive pretreatment of the recipient. Cell Immunol 75:271-282.
50. Taurog JD, Sandberg GP, Mahowald ML (1983) The cellular basis of adjuvant arthritis. II. Characterization of the cells mediating passive transfer. Cell Immunol 80:198-204.
51. Torfs CP, King MC, Huey B, Malmgren J, Grumet FC (1986) Genetic interrelationship between insulin-dependent diabetes mellitus, the autoimmune thyroid diseases, and rheumatoid arthritis. Am J Hum Genet 38:170-187.
52. VanEden W, Holoshitz J, Nevo Z, Frenkel A, Klajman A, Cohen IR (1985) Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans. Proc Natl Acad Sci USA 82:5117-5120.
53. VanEden W, Hogervorst EJM, Hensen EJ, Van Der Zee R, VanEmbden JDA, Cohen IR (1989) A cartilage-mimicking T-cell epitope on a 65K mycobacterial heat-shock protein: Adjuvant arthritis as a model for human rheumatoid arthritis. Curr Top Microbiol Immunol 145:27-43.
54. Waksman BH, Pearson CM, Sharp JT (1960) Studies of arthritis and other lesions induced in rats by injection of mycobacterial adjuvant. II. Evidence that the disease is a disseminated immunological response to exogenous antigen. J Immunol 85:403-417.
55. Waksman BH, Wennersten C (1963) Passive transfer of adjuvant arthritis with living lymphoid cells of sensitized donors. Int Arch Allergy 23:129-139.
56. Ward JR, Jones RS (1962) Studies on adjuvant-induced polyarthritis in rats. I. Adjuvant composition, route of injection, and removal of depot site. Arthritis Rheum 5:557-564.
57. Wilder RL, Remmers EF, Kawahito Y, Gulko PS, Cannon GW, Griffiths MM (1999) Genetic factors regulating experimental arthritis in mice and rats. In: Theophilopoulos AN (ed.) Current Directions in Autoimmunity. Karger, Basel, pp 121-165.
58. Williams RO (1998) Rodent models of arthritis: relevance for human disease. Clin Exp Immunol 114:330-332.
59. Yoshino S, Schlipkoter E, Kinne R, Hunig T, Emmrich F (1990) Suppression and prevention of adjuvant arthritis in rats by a monoclonal antibody to the a/b T cell receptor. Eur J Immunol 20:2805-2808.